DocGo Inc (DCGO) is gearing up for another turning point as it hit the volume of 0.6 million

DocGo Inc (NASDAQ: DCGO) on Tuesday, plunged -5.69% from the previous trading day, before settling in for the closing price of $4.04. Within the past 52 weeks, DCGO’s price has moved between $2.78 and $10.82.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Healthcare Sector giant saw their annual sales surged by 106.22% over the last five years. The company achieved an average annual earnings per share of 468.94%. With a float of $86.44 million, this company’s outstanding shares have now reached $104.06 million.

The firm has a total of 4100 workers. Let’s measure their productivity.

DocGo Inc (DCGO) Insider Activity

Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of DocGo Inc is 17.02%, while institutional ownership is 46.87%. The most recent insider transaction that took place on Mar 15 ’24, was worth 49,140. In this transaction Director of this company bought 13,500 shares at a rate of $3.64, taking the stock ownership to the 69,534 shares. Before that another transaction happened on Mar 14 ’24, when Company’s CFO and Treasurer bought 10,000 for $3.61, making the entire transaction worth $36,100. This insider now owns 274,222 shares in total.

DocGo Inc (DCGO) Earnings and Forecasts

As on 12/30/2023, Multinational firm has announced its last quarter scores, in which it reported $0.07 earnings per share (EPS) for the period falling under the consensus outlook (set at $0.1) by -$0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 468.94% per share during the next fiscal year.

DocGo Inc (NASDAQ: DCGO) Trading Performance Indicators

DocGo Inc (DCGO) is currently performing well based on its current performance indicators. A quick ratio of 1.99 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.64.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.06, a number that is poised to hit 0.08 in the next quarter and is forecasted to reach 0.47 in one year’s time.

Technical Analysis of DocGo Inc (DCGO)

Analysing the last 5-days average volume posted by the [DocGo Inc, DCGO], we can find that recorded value of 0.52 million was lower than the volume posted last year of 1.65 million. As of the previous 9 days, the stock’s Stochastic %D was 55.68%. Additionally, its Average True Range was 0.24.

During the past 100 days, DocGo Inc’s (DCGO) raw stochastic average was set at 25.00%, which indicates a significant decrease from 47.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.16% in the past 14 days, which was lower than the 102.52% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.71, while its 200-day Moving Average is $6.07. Now, the first resistance to watch is $3.93. This is followed by the second major resistance level at $4.06. The third major resistance level sits at $4.17. If the price goes on to break the first support level at $3.70, it is likely to go to the next support level at $3.59. Should the price break the second support level, the third support level stands at $3.46.

DocGo Inc (NASDAQ: DCGO) Key Stats

Market capitalization of the company is 396.89 million based on 104,171K outstanding shares. Right now, sales total 624,290 K and income totals 6,860 K. The company made 199,250 K in profit during its latest quarter, and 7,570 K in sales during its previous quarter.